India, Shringla stated, will participate fully in the international process of regeneration through building newer and more resilient supply chains, by focusing on newer technologies and knowledge-driven opportunities and leveraging Indias capacities.
Toggle navigation
Foreign Secretary Harsh Shringla speaking at WHO s South-East Asia Regional Health Partners Forum on COVID-19 (Source: Arindam Bagchi/Twitter)
India at WHO reiterates promise to create global scale capacities to face pandemic challenges ANI | Updated: Jun 03, 2021 15:06 IST
New Delhi [India], June 3 (ANI): Foreign SecretaryHarsh Shringla on Thursday reiterated that India will participate in the process of creating global scale capacities that are needed to deal with pandemic challenges and vowed to participate fully in the international process of regeneration through building newer and more resilient supply chains.
Speaking at a World Health Organization s (WHO) forum, Shringla said: We had to create, literally overnight, new capacities to try and cope with a Black Swan event. We have had to innovate, to repurpose and to re-engineer and create an entirely new vertical for pandemic diplomacy.
Foreign Secretary Harsh Shringla on Thursday reiterated that India will participate in the process of creating global scale capacities that are needed to deal w
File photo of India s Foreign Secretary Harsh Vardhan Shringla. | Harsh Vardhan Shringla/ Twitter
Foreign Secretary Harsh Vardhan Shringla on Thursday said that the Ministry of External Affairs is in talks with Covid-19 vaccine makers such as Pfizer, Johnson & Johnson and Moderna about sourcing and possibly manufacturing doses in India. The development comes as the country is trying to source more vaccines amid a shortage.
Speaking at the “South-East Asia Regional Health Partners’ Forum on Covid-19”, Shringala said the ministry also helped in expediting the introduction of Russia’s Sputnik-V vaccines in India.
India is currently using two vaccines – Bharat Biotech’s Covaxin and Serum Institute of India’s Covishield – to inoculate its population. India has also given emergency use authorisation to Russia’s Sputnik V.